Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 9 Cholangiocarcinoma 8 Pancreatic Neoplasms 7 Gallbladder Neoplasms 6 Ovarian Neoplasms 4 Esophageal Neoplasms 4 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Rectal Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Klatskin Tumor 2 Carcinoma, Hepatocellular 2 Anus Neoplasms 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdomyosarcoma 1 Resectable Intrahepatic Cholangiocarcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 PRETEXT I Hepatoblastoma 1 Mesothelioma, Malignant 1 Liposarcoma 1 Hepatoblastoma 1 Gastrointestinal Neoplasms 1 Gastric Adenocarcinoma 1 Fibrolamellar hepatocellular carcinoma 1

Interventions

Fluorouracil 9 Radiotherapy 7 Cisplatin 7 Radiotherapy, Intensity-Modulated 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiation 3 Nivolumab 3 Capecitabine 3 dehydroftorafur 2 Taxes 2 Paclitaxel 2 Cetuximab 2 Carboplatin 2 Biopsy 2 toripalimab 1 rocakinogene sifuplasmid 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 VGX-3100 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Platinum × Gastrointestinal × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡